查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1314477

局部止血劑市場：按產品和用途- 2023-2030 年全球預測

Topical Hemostat Market by Product, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球局部止血劑市場將大幅成長，達到41.0122億美元，複合年成長率為7.57%，預計到2030年將達到68.4754億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球局部止血劑市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球局部止血劑市場規模及預測為何？

2.在預測期內，COVID-19對全球局部止血劑市場的阻礙因素與影響為何？

3. 在預測期內，全球局部止血劑市場需要投資哪些產品/細分市場/用途/領域？

4.全球局部止血劑市場的競爭策略為何？

5.全球局部止血劑市場的技術趨勢和法律規範是什麼？

6.全球局部止血劑市場主要供應商的市佔率是多少？

7. 哪些型態和策略性措施被認為適合進入局部止血劑的全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 全球血管外科的潛在需求
      • 由於具有成本效益，用途增加
      • 醫療法規機構的有利產品核可
    • 抑制因素
      • 這些產品缺乏報銷政策
    • 機會
      • 微創手術新需求
      • 正在進行研發以推出新的局部止血劑
    • 任務
      • 局部止血劑的操作局限性
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 局部止血劑市場：副產品

  • 介紹
  • 膠原蛋白基底
  • 組合
  • 明膠基質
  • 氧化再生纖維素基
  • 凝血酶鹼基

第7章 局部止血劑市場：依用途

  • 介紹
  • 醫院
  • 療養院
  • 手術中心

第8章 美洲局部止血劑市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太本地局部劑市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲局部止血劑市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-031AB52F47EC

The Global Topical Hemostat Market is forecasted to grow significantly, with a projected USD 4,101.22 million in 2023 at a CAGR of 7.57% and expected to reach a staggering USD 6,847.54 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Topical Hemostat Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Topical Hemostat Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Collagen-Based Topical Hemostats, Combination Topical Hemostats, Gelatin-Based Topical Hemostats, Oxidized Regenerated Cellulose-based Topical Hemostats, and Thrombin-Based Topical Hemostats. The Thrombin-Based Topical Hemostats is projected to witness significant market share during forecast period.

Based on Application, market is studied across Hospitals, Nursing Homes, and Surgical Centers. The Nursing Homes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Topical Hemostat Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Topical Hemostat Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Topical Hemostat Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Topical Hemostat Market?

4. What is the competitive strategic window for opportunities in the Global Topical Hemostat Market?

5. What are the technology trends and regulatory frameworks in the Global Topical Hemostat Market?

6. What is the market share of the leading vendors in the Global Topical Hemostat Market?

7. What modes and strategic moves are considered suitable for entering the Global Topical Hemostat Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Topical Hemostat Market, by Product, 2022 vs 2030
  • 4.3. Topical Hemostat Market, by Application, 2022 vs 2030
  • 4.4. Topical Hemostat Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential demand in vascular surgeries across the world
      • 5.1.1.2. Increasing application attributed to its cost-effective nature
      • 5.1.1.3. Favorable product approval by medical regulators
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of reimbursement policies for these products
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging demand for minimally invasive surgical procedures
      • 5.1.3.2. Ongoing R&D for the introduction of novel topical hemostat
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations of topical hemostat
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Topical Hemostat Market, by Product

  • 6.1. Introduction
  • 6.2. Collagen-Based Topical Hemostats
  • 6.3. Combination Topical Hemostats
  • 6.4. Gelatin-Based Topical Hemostats
  • 6.5. Oxidized Regenerated Cellulose-based Topical Hemostats
  • 6.6. Thrombin-Based Topical Hemostats

7. Topical Hemostat Market, by Application

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Nursing Homes
  • 7.4. Surgical Centers

8. Americas Topical Hemostat Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Topical Hemostat Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Topical Hemostat Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. TOPICAL HEMOSTAT MARKET RESEARCH PROCESS
  • FIGURE 2. TOPICAL HEMOSTAT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. TOPICAL HEMOSTAT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. TOPICAL HEMOSTAT MARKET DYNAMICS
  • FIGURE 8. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. TOPICAL HEMOSTAT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. TOPICAL HEMOSTAT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. TOPICAL HEMOSTAT MARKET SIZE, BY COLLAGEN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. TOPICAL HEMOSTAT MARKET SIZE, BY COMBINATION TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. TOPICAL HEMOSTAT MARKET SIZE, BY GELATIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. TOPICAL HEMOSTAT MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. TOPICAL HEMOSTAT MARKET SIZE, BY THROMBIN-BASED TOPICAL HEMOSTATS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. TOPICAL HEMOSTAT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. TOPICAL HEMOSTAT MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. TOPICAL HEMOSTAT MARKET SIZE, BY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM TOPICAL HEMOSTAT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TOPICAL HEMOSTAT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 101. TOPICAL HEMOSTAT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 102. TOPICAL HEMOSTAT MARKET LICENSE & PRICING